UBE2V2 Antikörper (AA 2-145)
-
- Target Alle UBE2V2 Antikörper anzeigen
- UBE2V2 (Ubiquitin-Conjugating Enzyme E2 Variant 2 (UBE2V2))
-
Bindungsspezifität
- AA 2-145
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser UBE2V2 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA, Immunohistochemistry (IHC)
- Kreuzreaktivität
- Human, Maus, Ratte
- Aufreinigung
- >95%, Protein G purified
- Immunogen
- Recombinant Human Ubiquitin-conjugating enzyme E2 variant 2 protein (2-145AA)
- Isotyp
- IgG
-
-
- Applikationshinweise
- Recommended dilution: WB:1:500-1:5000, IHC:1:20-1:200,
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4 - Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Target
- UBE2V2 (Ubiquitin-Conjugating Enzyme E2 Variant 2 (UBE2V2))
- Andere Bezeichnung
- UBE2V2 (UBE2V2 Produkte)
- Synonyme
- DDVIT1 antikoerper, DDVit-1 antikoerper, EDAF-1 antikoerper, EDPF-1 antikoerper, EDPF1 antikoerper, MMS2 antikoerper, UEV-2 antikoerper, UEV2 antikoerper, mms2 antikoerper, uev2 antikoerper, edpf1 antikoerper, uev-2 antikoerper, ddvit1 antikoerper, edaf-1 antikoerper, edpf-1 antikoerper, ddvit-1 antikoerper, 1110021H13Rik antikoerper, 4632410D19Rik antikoerper, 5730524P06Rik antikoerper, 6820402M05 antikoerper, AI848315 antikoerper, C81524 antikoerper, wu:fb18b11 antikoerper, wu:fb24d11 antikoerper, zgc:63717 antikoerper, UBE2V2 antikoerper, TMEM189-UBE2V1 antikoerper, ubiquitin conjugating enzyme E2 V2 antikoerper, ubiquitin-conjugating enzyme E2 variant 2 antikoerper, ubiquitin conjugating enzyme E2 V2 S homeolog antikoerper, Ubiquitin-conjugating enzyme E2 variant 2 antikoerper, UBE2V2 antikoerper, Ube2v2 antikoerper, ube2v2 antikoerper, ube2v2.S antikoerper, PTRG_00824 antikoerper, ub2v2 antikoerper, Tsp_08004 antikoerper
- Hintergrund
-
Background: Has no ubiquitin ligase activity on its own. The UBE2V2/UBE2N heterodimer catalyzes the synthesis of non-canonical poly-ubiquitin chains that are linked through \\\'Lys-63\\\'. This type of poly-ubiquitination does not lead to protein degradation by the proteasome. Mediates transcriptional activation of target genes. Plays a role in the control of progress through the cell cycle and differentiation. Plays a role in the error-free DNA repair pathway and contributes to the survival of cells after DNA damage.
Aliases: 1 alpha 25 dihydroxyvitamin D3 inducible antibody, DDVit 1 antibody, DDVIT1 antibody, EDAF-1 antibody, EDAF1 antibody, EDPF-1 antibody, EDPF1 antibody, Enterocyte differentiation associated factor EDAF 1 antibody, Enterocyte differentiation promoting factor antibody, Enterocyte differentiation-associated factor 1 antibody, Enterocyte differentiation-promoting factor 1 antibody, Methyl methanesulfonate sensitive 2 antibody, MMS 2 antibody, MMS2 antibody, MMS2 homolog antibody, UB2V2_HUMAN antibody, UBE2V 2 antibody, UBE2V2 antibody, Ubiquitin conjugating enzyme E2 variant 2 antibody, Ubiquitin conjugating enzyme E2v2 antibody, Ubiquitin-conjugating enzyme E2 variant 2 antibody, UEV 2 antibody, UEV2 antibody, Vitamin D3 inducible protein antibody, Vitamin D3-inducible protein antibody
- UniProt
- Q15819
- Pathways
- Positive Regulation of Response to DNA Damage Stimulus
-